Certolizumab pegol in rheumatoid arthritis: current update

Author： Fechtenbaum Marie   Md Yusof Md Yuzaiful   Emery Paul  

Publisher： Informa Healthcare

ISSN： 1471-2598

Source： Expert Opinion on Biological Therapy, Vol.14, Iss.6, 2014-06, pp. : 841-850

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Related content

The clinical efficacy and safety of certolizumab pegol in rheumatoid arthritis

By Fleischmann Roy  

Expert Opinion on Biological Therapy, Vol. 10, Iss. 5, 2010-05 ,pp. : 773-786

Informa Healthcare

Access to resources Recommend Favorite

CDP-870 (certolizumab) in rheumatoid arthritis

By Kaushik V   Moots RJ  

Expert Opinion on Biological Therapy, Vol. 5, Iss. 4, 2005-04 ,pp. : 601-606

Informa Healthcare

Access to resources Recommend Favorite

Certolizumab pegol in the treatment of Crohn's disease

By Ferrante Marc   Vermeire Séverine   Rutgeerts Paul  

Expert Opinion on Biological Therapy, Vol. 13, Iss. 4, 2013-04 ,pp. : 595-605

Informa Healthcare

Access to resources Recommend Favorite

Gene therapy for rheumatoid arthritis

By Ghivizzani Steven C   Gouze Elvire   Gouze Jean-Noel   Palmer Glyn D   Evans Christopher H   Robbins Paul D  

Expert Opinion on Biological Therapy, Vol. 1, Iss. 6, 2001-11 ,pp. : 971-978

Informa Healthcare

Access to resources Recommend Favorite

Adalimumab in the treatment of rheumatoid arthritis

By Voulgari Paraskevi V   Kaltsonoudis Evripidis   Papagoras Charalampos   Drosos Alexandros A  

Expert Opinion on Biological Therapy, Vol. 12, Iss. 12, 2012-12 ,pp. : 1679-1686

Informa Healthcare

Access to resources Recommend Favorite